Literature DB >> 21130902

Systematic review: diagnostic accuracy of clinical decision rules for venous thromboembolism in elderly.

R N Siccama1, K J M Janssen, N A F Verheijden, R Oudega, L Bax, J J M van Delden, K G M Moons.   

Abstract

BACKGROUND: Physicians committed to the care of elderly patients, are challenged with the diagnosis of venous thromboembolism (VTE: deep venous thrombosis and pulmonary embolism) due to a higher incidence, co-morbidities masking signs and symptoms and burdening referrals. Clinical decision rules (CDRs) have been developed and implemented for VTE. Yet, until now, no study has evaluated the existing evidence of the diagnostic accuracy of CDRs for VTE in elderly.
PURPOSE: To assess the effect of increasing age on diagnostic accuracy of CDRs for VTE in elderly. DATA SOURCES: A computerized systematic search was performed in Medline and Embase from 1950 to 2010. After checking reference lists and field experts, all key journals were hand searched. STUDY SELECTION: After review of 1538 eligible citations, nine articles were included and critically appraised on methodological quality by two reviewers using the QUADAS criteria. DATA EXTRACTION: Data on age subgroups, type of CDRs, sensitivity, specificity, safety, efficiency and the prevalence of deep venous thrombosis (DVT) and pulmonary embolism (PE) were extracted. DATA SYNTHESIS: Although sensitivity and safety of the CDRs for VTE in elderly remained high, the specificity and efficiency decreased substantially in older age groups. LIMITATIONS: A limited number of studies met our inclusion criteria. Possible referral bias due to inclusion of relatively high risk elderly patients.
CONCLUSIONS: This diagnostic review demonstrates an increase of prevalence of PE with age and a strong decrease of specificity and efficiency for CDRs of VTE in older patients. Moreover, due to referral bias the decrease in specificity in the elderly may even be underestimated. Although the safety of CDRs for VTE is high, adapting these rules for elderly is much needed to make them more efficient for aged patients.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21130902     DOI: 10.1016/j.arr.2010.10.005

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  5 in total

Review 1.  Managing pulmonary embolism using prognostic models: future concepts for primary care.

Authors:  Geert-Jan Geersing; Ruud Oudega; Arno W Hoes; Karel G M Moons
Journal:  CMAJ       Date:  2011-12-05       Impact factor: 8.262

2.  Validation of two age dependent D-dimer cut-off values for exclusion of deep vein thrombosis in suspected elderly patients in primary care: retrospective, cross sectional, diagnostic analysis.

Authors:  Henrike J Schouten; H L Dineke Koek; Ruud Oudega; Geert-Jan Geersing; Kristel J M Janssen; Johannes J M van Delden; Karel G M Moons
Journal:  BMJ       Date:  2012-06-06

3.  Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project.

Authors:  Bernd Frank; Liana Ariza; Heidrun Lamparter; Vera Grossmann; Jürgen H Prochaska; Alexander Ullmann; Florentina Kindler; Gerhard Weisser; Ulrich Walter; Karl J Lackner; Christine Espinola-Klein; Thomas Münzel; Stavros V Konstantinides; Philipp S Wild
Journal:  BMJ Open       Date:  2015-07-01       Impact factor: 2.692

4.  [Cost-effectiveness of the deep vein thrombosis diagnosis process in primary care].

Authors:  Eva Fuentes Camps; José Luis del Val García; Sergi Bellmunt Montoya; Sara Hmimina Hmimina; Efren Gómez Jabalera; Miguel Ángel Muñoz Pérez
Journal:  Aten Primaria       Date:  2015-08-19       Impact factor: 1.137

5.  Predicting perioperative venous thromboembolism in Japanese gynecological patients.

Authors:  Masae Ikeda; Hidetoshi Kan-no; Masaru Hayashi; Hitomi Tsukada; Masako Shida; Takeshi Hirasawa; Toshinari Muramatsu; Yoichi Ogushi; Mikio Mikami
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.